STOCK TITAN

Ngm Biopharmaceuticals Inc - NGM STOCK NEWS

Welcome to our dedicated news page for Ngm Biopharmaceuticals (Ticker: NGM), a resource for investors and traders seeking the latest updates and insights on Ngm Biopharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ngm Biopharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ngm Biopharmaceuticals's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.99%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.41%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.41%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-70.48%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-70.48%
Tags
conferences clinical trial
Ngm Biopharmaceuticals Inc

Nasdaq:NGM

NGM Rankings

NGM Stock Data

135.21M
28.89M
21.08%
54.16%
1.95%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
South San Francisco

About NGM

ngm bio is a research-driven, clinical stage biopharmaceutical company with a drug discovery platform designed to generate a pipeline of first-in-class biologic drug candidates. our initial r&d focus has been on cardio-metabolic and liver disease, but we believe that our research expertise – comprehensive and grounded in fundamental, interrelated mechanisms of human biology – is capable of driving the development of new therapies for a wide range of disease areas such as cancer. ngm bio’s comprehensive approach to drug discovery focuses on elucidating the biology of hormones, cell receptors and associated ligands. as we investigate these novel biological mechanisms, we assemble a deep understanding of the relationship between the structure and function of proteins of interest. coupled with our experience in protein and antibody engineering, our approach enables the efficient and targeted generation of potential first-in-class therapeutics with optimized pharmacologic profiles. work